GENFIT (EPA:GNFT) GENFIT: Results from Ipsen’s ELATIVE® pivotal Phase III trial of elafibranor in PBC presented as late breaking data at AASLD congress and published in New England Journal of Medicine
Transparency directive : regulatory news
13/11/2023 22:30
GENFIT's latest news
25/04/2024 22:10
15/04/2024 22:10
05/04/2024 20:00
29/02/2024 22:10
15/01/2024 22:10
11/01/2024 22:10
07/12/2023 11:15
16/11/2023 22:10
13/11/2023 22:30
09/11/2023 22:10
Other stories
27/04/2024 13:29
26/04/2024 17:15
27/04/2024 10:39
27/04/2024 10:04
26/04/2024 22:20
Teacher dramatically admits mid-trial to murdering boyfriend she buried in garden - Evening Standard
27/04/2024 13:36
27/04/2024 12:06
26/04/2024 19:02
27/04/2024 12:24
27/04/2024 13:30
27/04/2024 10:27
27/04/2024 04:51
27/04/2024 03:13
26/04/2024 23:49
26/04/2024 18:53
26/04/2024 23:01
26/04/2024 18:00
27/04/2024 00:36
27/04/2024 01:21
27/04/2024 08:30
27/04/2024 08:30
27/04/2024 10:04
27/04/2024 08:10
26/04/2024 23:16
27/04/2024 10:16
26/04/2024 21:09
27/04/2024 13:08
27/04/2024 08:43
27/04/2024 11:29
27/04/2024 12:00
27/04/2024 13:17
27/04/2024 01:12
26/04/2024 20:00
26/04/2024 10:24
26/04/2024 13:30
27/04/2024 12:48
26/04/2024 22:00
26/04/2024 10:48